REQUEST A DEMO
Total
USD $0.00
Search more companies

Bicro Biocentar d.o.o. (Croatia)

Main Activities: Research and Development in Nanotechnology | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Bicro Biocentar d.o.o. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Bicro Biocentar d.o.o. is based in Croatia, with the head office in Zagreb. It operates in the Research and Development in Nanotechnology sector. The company was established on January 03, 2026. There are currently 21 (2024) people employed by Bicro Biocentar d.o.o.. The latest financial highlights indicate a net sales revenue increase of 17.28% in 2024. During that time, Bicro Biocentar d.o.o.’s total assets grew by 25.83%. The net profit margin of Bicro Biocentar d.o.o. decreased by 1.44% in 2024.

Headquarters
Borongajska Cesta 83H Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Bicro Biocentar d.o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Bicro Biocentar d.o.o. report to view the information.
Financial Auditors:
Purchase the Bicro Biocentar d.o.o. report to view the information.
Incorporation Date:
January 03, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Bicro Biocentar d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
17.28%
Total operating revenue
17.28%
Operating profit (EBIT)
-22.62%
EBITDA
68.97%
Net Profit (Loss) for the Period
-48.76%
Total assets
25.83%
Total equity
12.51%
Operating Profit Margin (ROS)
-1.01%
Net Profit Margin
-1.44%
Return on Equity (ROE)
-13.05%
Debt to Equity Ratio
-57.05%
Quick Ratio
-0.04%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?